Elsevier

Psychiatry Research: Neuroimaging

Volume 266, 30 August 2017, Pages 10-18
Psychiatry Research: Neuroimaging

Brain neurodevelopmental markers related to the deficit subtype of schizophrenia

https://doi.org/10.1016/j.pscychresns.2017.05.007Get rights and content

Highlights

  • Deficit schizophrenia is a clinical subtype with prominent negative symptoms.

  • This MRI study examined gross brain morphology in deficit and non-deficit subgroups.

  • Deficit group had a shorter adhesio interthalamica and altered sulcogyral pattern.

  • Deficit subtype schizophrenia may have pervasive neurodevelopmental abnormalities.

Abstract

Deficit schizophrenia is a homogeneous subtype characterized by a trait-like feature of primary and prominent negative symptoms, but the etiologic factors related to this specific subtype remain largely unknown. This magnetic resonance imaging study aimed to examine gross brain morphology that probably reflects early neurodevelopment in 38 patients with deficit schizophrenia, 37 patients with non-deficit schizophrenia, and 59 healthy controls. Potential brain neurodevelopmental markers investigated in this study were the adhesio interthalamica (AI), cavum septi pellucidi (CSP), and surface morphology (i.e., olfactory sulcus depth, sulcogyral pattern, and number of orbital sulci) of the orbitofrontal cortex (OFC). The subtype classification of schizophrenia patients was based on the score of Proxy for the Deficit Syndrome. The deficit schizophrenia group had a significantly shorter AI compared with the non-deficit group and controls. The deficit group, but not the non-deficit group, was also characterized by an altered distribution of the OFC sulcogyral pattern, as well as fewer posterior orbital sulcus compared with controls. Other neurodevelopmental markers did not differentiate the deficit and non-deficit subgroups. These results suggest that the deficit subtype of schizophrenia and its clinical manifestation may be at least partly related to prominent neurodevelopmental pathology.

Introduction

Detailed examination of specific schizophrenia subtypes is one possible approach to reduce heterogeneity, which could partly explain the discrepant neurobiological findings of the disorder (Keshavan et al., 2008, van Os and Kapur, 2009). Deficit schizophrenia is a clinical subtype characterized by primary and prominent negative symptoms that persist even during periods of relative remission (Carpenter et al., 1988). While etiologic factors related to this specific subtype remain elusive, the association of deficit schizophrenia with poor premorbid adjustment (Bucci et al., 2016, Kirkpatrick and Galderisi, 2008), neurological abnormalities (Peralta et al., 2014), and general cognitive impairments (reviewed by Mucci et al., in press) may support the hypothesis of its pervasive neurodevelopmental abnormalities (Galderisi et al., 2002, Peralta et al., 2014). Furthermore, a recent magnetic resonance imaging (MRI) study of network-level properties of cortical thickness demonstrated altered intracortical relationships, which may reflect reduced network differentiation during early neurodevelopment, in deficit schizophrenia (Wheeler et al., 2015). To our knowledge, however, no MRI studies have examined gross brain morphology closely associated with early neurodevelopment specifically in deficit schizophrenia.

Previous MRI studies of gross brain morphology in schizophrenia have implicated the role of aberrant neurodevelopmental processes in the pathophysiology of schizophrenia (Pantelis et al., 2005). A smaller adhesio interthalamica (AI), which is a narrow bridge connecting the medial surfaces of the thalami that develops during early gestation (O'Rahilly and Muller, 1990, Rosales et al., 1968), and increased prevalence of large (e.g., ≥6 mm in anterior-posterior length) cavum septi pellucidi (CSP) due to incomplete fusion of the septum pellucidum around birth (Rakic and Yakovlev, 1968) are thought to reflect early developmental characteristics in midline brain regions in schizophrenia (Landin-Romero et al., 2016, Trzesniak et al., 2011a, 2011b). However, a large number of MRI studies including our own study (Takahashi et al., 2007, Takahashi et al., 2013b) reported normal size of the CSP in schizophrenia (reviewed by Trzesniak et al., 2011b). The surface morphology of the orbitofrontal cortex (OFC) is also a potential neurodevelopmental marker because it is largely established by birth (Armstrong et al., 1995, Chi et al., 1977); schizophrenia patients are generally characterized by a shallower olfactory sulcus (Nishikawa et al., 2016, Takahashi et al., 2013a, Takahashi et al., 2014), decreased Type I and increased Type III expression in the variation of the OFC ‘H-shaped’ sulcus [Type I, II, and III; defined by Chiavaras and Petrides (2000)] (Chakirova et al., 2010, Nakamura et al., 2007, Takayanagi et al., 2010), as well as a decreased number of intermediate and posterior orbital sulci (IOS/POS) (Bartholomeusz et al., 2013, Takahashi et al., 2016). We have previously demonstrated that AI length and number of POS are related to the severity of negative symptoms in schizophrenia (Takahashi et al., 2008a, Takahashi et al., 2016). Further, nucleus accumbens atrophy (De Rossi et al., 2016) as well as microstructural disruption of the forceps minor (Spalletta et al., 2015) in deficit schizophrenia may imply significant role of the OFC abnormalities in this clinical subtype, because both of these structures are functionally and structurally connected with the OFC (Catani and Thiebaut de Schotten, 2008, Diekhof et al., 2012). However, it remains largely unknown whether the deficit and non-deficit subtypes of schizophrenia have differences in the morphology of potential neurodevelopmental markers located in the midline and OFC regions.

This MRI study aimed to expand our previous studies of a range of neurodevelopmental markers [AI (Takahashi et al., 2008a, Takahashi et al., 2008b), CSP (Takahashi et al., 2007), olfactory sulcus (Nishikawa et al., 2016, Takahashi et al., 2013a), and OFC surface morphology (Nishikawa et al., 2016, Takahashi et al., 2016)] in schizophrenia by investigating the characteristics of these neurodevelopmental markers in well-defined deficit subtype schizophrenia in comparison with non-deficit subtype as well as healthy controls. On the basis of hypothesized pervasive neurodevelopmental abnormalities in deficit schizophrenia (Galderisi et al., 2002, Peralta et al., 2014), we predicted that the deficit patients would exhibit greater changes in brain neurodevelopmental markers compared with the non-deficit patients. We also investigated the association between brain neurodevelopmental markers and clinical variables in each schizophrenia subgroup. Given the role of gross brain morphology as a stable trait marker that mainly reflects early neurodevelopment, we predicted that it would not be related to the symptom severity (especially positive symptoms) at scanning and potential confounding factors after illness onset (e.g., medication, illness duration).

Section snippets

Subjects

Seventy-five patients with schizophrenia (38 deficit and 37 non-deficit subtypes) fulfilling the ICD-10 research criteria (World Health Organization, 1993), who were recruited from the inpatient and outpatient clinics of the Department of Neuropsychiatry of Toyama University Hospital, were included in this study. The patients were diagnosed following a structured clinical interview by psychiatrists using the Comprehensive Assessment of Symptoms and History (CASH; Andreasen et al., 1992).

Demographic characteristics

Demographic and clinical characteristics of the study participants are summarized in Table 1. Age, gender, and parental education did not differ significantly between the groups, but the healthy controls had attained a higher level of education compared with the schizophrenia subgroups. The handedness distribution differed between the groups. The deficit and non-deficit schizophrenia subgroups did not differ in onset age, illness duration, and medication. There were significant

Discussion

To our knowledge, this is the first MRI study that demonstrated greater morphologic changes in several neurodevelopmental markers in deficit schizophrenia. The length of the AI was significantly shorter in patients with deficit schizophrenia compared to those with non-deficit schizophrenia and control subjects. Furthermore, alteration of the OFC sulcogyral pattern (H-shaped variation and sulcus count) was more evident in the deficit schizophrenia group than in the non-deficit group. However,

Conclusion

The present MRI study of gross brain morphology demonstrated that the deficit schizophrenia group was characterized by shorter AI and more evident changes in the OFC sulcogyral pattern compared with the non-deficit group. Given the potential role of these brain structures as a marker of early neurodevelopment, our findings may support the hypothesis, based on the clinical characteristics of deficit schizophrenia, that this specific subtype is associated with pervasive neurodevelopmental

Contributors

In this study, Drs. Suzuki and Takayanagi conceived the idea and methodology of the study. Dr. Takahashi conducted the statistical analyses and wrote the manuscript. Drs. Takahashi, Takayanagi, Furuichi, Kido, Nishikawa, Sasabayashi, and Nakamura recruited subjects, and were involved in clinical and diagnostic assessments. Drs. Takahashi, Nishikawa, and Nakamura analyzed the MRI data. Ms. Komori assisted in the management of clinical data of the study participants. Dr. Noguchi provided

Conflict of interest

None.

Acknowledgements

This work was supported by JSPS KAKENHI Grant number JP26461738 to Y.T., JP26461739 to T.T., and JP24390281 to M.S., and by the Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities from the Japan Agency for Medical Research and Development (AMED) Grant Number 16dk0307029h0003 to M.S. The authors would like to thank the radiological technologists, especially Mr. Koichi Mori and Mr. Sadanori Ito, who assisted in the MRI data collection at Toyama

References (78)

  • K. Kasai et al.

    Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study

    Schizophr. Res.

    (2004)
  • Y. Kawasaki et al.

    Anomalous cerebral asymmetry in patients with schizophrenia demonstrated by voxel-based morphometry

    Biol. Psychiatry

    (2008)
  • M.S. Keshavan et al.

    Schizophrenia,“Just the facts”: what we know in 2008 Part 3

    Neurobiol. Schizophr. Res.

    (2008)
  • B. Kirkpatrick et al.

    The Schedule for the Deficit syndrome: an instrument for research in schizophrenia

    Psychiatry Res.

    (1989)
  • B. Kirkpatrick et al.

    Case identification and stability of the deficit syndrome of schizophrenia

    Psychiatry Res.

    (1993)
  • B. Kirkpatrick et al.

    The deficit syndrome in the Suffolk County Mental Health Project

    Schizophr. Res.

    (1996)
  • M.L. Kringelbach et al.

    The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology

    Prog. Neurobiol.

    (2004)
  • S. Lavoie et al.

    Sulcogyral pattern and sulcal count of the orbitofrontal cortex in individuals at ultra high risk for psychosis

    Schizophr. Res.

    (2014)
  • E.M. Meisenzahl et al.

    Investigation of a possible diencephalic pathology in schizophrenia

    Psychiatry Res.

    (2002)
  • P. Nopoulos et al.

    Cavum septi pellucidi in normals and patients with schizophrenia as detected by magnetic resonance imaging

    Biol. Psychiatry

    (1997)
  • G. Percheron

    Thalamus

  • M.A. Roy et al.

    Male gender is associated with deficit schizophrenia: a meta-analysis

    Schizophr. Res.

    (2001)
  • G. Spalletta et al.

    Brain white matter microstructure in deficit and non-deficit subtypes of schizophrenia

    Psychiatry Res.

    (2015)
  • K.L. Subotnik et al.

    Prediction of the deficit syndrome from initial deficit symptoms in the early course of schizophrenia

    Psychiatry Res.

    (1998)
  • T. Takahashi et al.

    Prevalence of large cavum septi pellucidi and its relation to the medial temporal lobe structures in schizophrenia spectrum

    Prog. Neuropsychopharmacol. Biol. Psychiatry

    (2007)
  • T. Takahashi et al.

    Association between absence of the adhesio interthalamica and amygdala volume in schizophrenia

    Psychiatry Res.

    (2008)
  • T. Takahashi et al.

    Prevalence and length of the adhesio interthalamica in schizophrenia spectrum disorders

    Psychiatry Res.

    (2008)
  • T. Takahashi et al.

    Adhesio interthalamica in individuals at high-risk for developing psychosis and patients with psychotic disorders

    Prog. Neuropsychopharmacol. Biol. Psychiatry

    (2008)
  • T. Takahashi et al.

    Altered depth of the olfactory sulcus in first-episode schizophrenia

    Prog. Neuropsychopharmacol. Biol. Psychiatry

    (2013)
  • T. Takahashi et al.

    Longitudinal MRI study of the midline brain regions in first-episode schizophrenia

    Psychiatry Res.

    (2013)
  • T. Takahashi et al.

    Altered depth of the olfactory sulcus in ultra high-risk individuals and patients with psychotic disorders

    Schizophr. Res.

    (2014)
  • T. Takahashi et al.

    Decreased number of orbital sulci in schizophrenia spectrum disorders

    Psychiatry Res.

    (2016)
  • M. Takayanagi et al.

    Reduced anterior cingulate gray matter volume and thickness in subjects with deficit schizophrenia

    Schizophr. Res.

    (2013)
  • Y. Takayanagi et al.

    Volume reduction and altered sulco-gyral pattern of the orbitofrontal cortex in first-episode schizophrenia

    Schizophr. Res.

    (2010)
  • L. Tomelleri et al.

    Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia

    Eur. Neuropsychopharmacol.

    (2009)
  • C. Trzesniak et al.

    Adhesio interthalamica alterations in schizophrenia spectrum disorders: a systematic review and meta-analysis

    Prog. Neuropsychopharmacol. Biol. Psychiatry

    (2011)
  • C. Trzesniak et al.

    Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis

    Schizophr. Res.

    (2011)
  • J. van Os et al.

    Schizophrenia

    Lancet

    (2009)
  • U. Volpe et al.

    Dorsolateral prefrontal cortex volume in patients with deficit or nondeficit schizophrenia

    Prog. Neuropsychopharmacol. Biol. Psychiatry

    (2012)
  • Cited by (0)

    View full text